Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Disclosures
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

This protocol describes a straightforward and economical method for evaluating the effectiveness of potential photosensitizers in antibacterial photodynamic inactivation (aPDI), using a 96-well plate format combined with an LED panel light source. This approach enables the simultaneous testing of multiple experimental conditions, including different concentrations, compounds, and bacterial strains.

Abstract

The rise of multi-drug-resistant infections and the lack of new antibiotic classes have renewed interest in alternative therapies like photodynamic inactivation of bacteria (aPDI). This process involves the administration of a photosensitizer (PS) activated by a suitable visible light source, producing exacerbated levels of reactive oxygen species (ROS) that damage crucial cellular biomolecules, ultimately causing bacterial cell death. It is crucial to create standardized, easy-to-use, and reproducible initial tests to assess and compare the effectiveness of light-induced phototoxicity of potential photosensitizers. This study introduces a simple and efficient in vitro technique for assessing photodynamic activity against planktonic bacterial cells. By employing a 96-well microplate format along with a large LED panel, the system facilitates the systematic evaluation of various compounds. Such a configuration allows for high-throughput screening of potential photosensitizers in a controlled and consistent environment, simplifying the process of identifying promising candidates for further development. This flexible platform serves as an important step in advancing the development of innovative photodynamic therapies for managing antibiotic-resistant infections.

Introduction

Photodynamic therapy (PDT) is a minimally invasive therapeutic approach that has shown promising results in recent years, particularly in dermatological clinical treatment1. One particularly interesting area of application of this therapeutic modality is the treatment of microbial infections, a process known as antimicrobial photodynamic inactivation (aPDI)2. Although initially overlooked, mostly because of the remarkable efficiency of antibiotics, light-triggered eradication of bacterial growth underwent a renewed interest over the recent years, driven by the emergence of antimicrobial multidrug resistance (AMR) and the....

Protocol

An overall description of the protocol is illustrated in Figure 1. The details of the reagents and equipment used are listed in the Table of Materials.

1. Bacterial culture preparation

  1. Grow S. aureus (ATCC 29213) bacteria on Mueller-Hinton agar (MH) from stock cultures. Incubate the MH plates at 37 °C for 24 h prior to the assay to obtain fresh cultures.
  2. Inoculate bacteria: Collect 2-3 fresh colonies from the ag.......

Representative Results

Amino-based flavylium compounds (Figure 2): 7-diethylamino-4′-dimethylaminoflavylium (7NEt24′NMe2), 7-diethylamino-2-(dimethylaminostyryl)-1-benzopyrylium (7NEt2st4′NMe2), 7-diethylamino-4′-aminoflavylium(7NEt24′NH2) and 7-diethylamino-4′-hydroxyflavylium (7NEt24′OH), whose light responsive nature was previously discussed12,

Discussion

Although this protocol serves as an initial stage testing platform, it is important to consider more meaningful testing conditions for the treatment of microbial infections in a more advanced study phase. When assessing the effectiveness of aPDI, experiments on biofilm-type bacterial organizations rather than planktonic bacteria should be conducted. Many clinical cases involve microorganisms organized in this more resistant conformation, such as chronic wounds, cystic fibrosis, and on implanted medical devices

Disclosures

The authors have nothing to disclose.

Acknowledgements

This work was financially supported by FCT project FERMEN.TO - FERmented foods to struggle MEtabolic syNdrome. An inTegrated in vitro dynamic approach (2023.00164.RESTART). This work was supported by the Associate Laboratory for Green Chemistry - LAQV (LA/P/0008/2020 https://doi.org/10.54499/LA/P/0008/2020; UIDP/50006/2020 https://doi.org/10.54499/UIDP/50006/2020; UIDB/50006/2020 https://doi.org/10.54499/UIDB/50006/2020) which national funds finance from FCT/MCTES. P.C. thanks her PhD grant from FCT (SFRH/BD/150661/2020). Iva Fernandes acknowledges her assistant professor contract (https://doi.org/10.54499/CEECINST/00064/2021/CP2812/CT0004).

....

Materials

NameCompanyCatalog NumberComments
Cary 60 UV-Vis SpectrophotometerAgilentG6860A
Dimethyl SulfoxideSigma-AldrichD8418
Disposable cuvettes PMMABRAND GMBH + CO KG759030
Eppendorfs (500 mL)Fisher Scientific15625367
Falcon tubes (15 mL)Corning430791
Falcon tubes (50 mL)Corning430291
LED panel IP65 50W
Micropippete (100 uL)Transferpette S705874
Micropippete (1000 uL)Transferpette S705880
Mueller Hinton agar OxoidCM0405
Multichannel pippete 12-channelTransferpette S
Nunc MicroWell 96-Well MicroplatesThermo Scientific260844
Phospate Buffered Saline tablets pH 7.4Panreac ApplichemA9177
Serological Pipets (10 mL)Thermo Scientific170356N
Serological Pipets (5 mL)Thermo Scientific170366N
Tissue Culture DishTPP Techno Plastic Products AG93150

References

  1. Correia, J. H., Rodrigues, J. A., Pimenta, S., Dong, T., Yang, Z. Photodynamic therapy review: principles, photosensitizers, applications, and future directions. Pharmaceutics. 13 (9), 1332 (2021).
  2. Hamblin, M. R.

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Explore More Articles

Biochemistry

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved